Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Theralase Technologies Inc (TLTFF)

Theralase Technologies Inc (TLTFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Theralase Expands Intellectual Property Portfolio Globe Newswire - Tue Jun 28, 2022

TORONTO, June 28, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...

TLT.VN : 0.155 (-3.12%)
TLTFF : 0.1130 (-3.00%)
Theralase® Research - One of the Top 10 Most Downloaded Papers Globe Newswire - Fri Jun 24, 2022

TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...

TLT.VN : 0.155 (-3.12%)
TLTFF : 0.1130 (-3.00%)
Theralase® Phase Ib NMIBC Clinical Study Published Globe Newswire - Tue Jun 21, 2022

TORONTO, June 21, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...

TLT.VN : 0.155 (-3.12%)
TLTFF : 0.1130 (-3.00%)
Theralase Releases Q122 Interim Financial Statements Globe Newswire - Mon May 30, 2022

TORONTO, May 30, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...

TLT.VN : 0.155 (-3.12%)
TLTFF : 0.1130 (-3.00%)
Theralase Release FY2021 Audited Financial Statements Globe Newswire - Fri Apr 29, 2022

TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...

TLT.VN : 0.155 (-3.12%)
TLTFF : 0.1130 (-3.00%)
Theralase® Provides Update on Phase II Bladder Cancer Clinical Study Globe Newswire - Tue Apr 5, 2022

TORONTO, April 05, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...

TLT.VN : 0.155 (-3.12%)
TLTFF : 0.1130 (-3.00%)
Theralase® Demonstrates Proof-of-Concept for Canadian-Made COVID-19 Vaccine Globe Newswire - Mon Feb 7, 2022

TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...

TLT.VN : 0.155 (-3.12%)
TLTFF : 0.1130 (-3.00%)
Theralase Expands Intellectual Property Portfolio Globe Newswire - Thu Dec 9, 2021

TORONTO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...

TLT.VN : 0.155 (-3.12%)
TLTFF : 0.1130 (-3.00%)
Theralase Releases 3Q21 Financial Statements and Newsletter Globe Newswire - Mon Nov 29, 2021

TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...

TLT.VN : 0.155 (-3.12%)
TLTFF : 0.1130 (-3.00%)
Theralase Announces Leadership Reorganization Globe Newswire - Mon Nov 15, 2021

TORONTO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...

TLT.VN : 0.155 (-3.12%)
TLTFF : 0.1130 (-3.00%)

Barchart Exclusives

3 Monthly Income Stocks That Just Raised Their Dividends Barchart - Mon Apr 29, 6:30PM CDT
Discover how these three standout REITs are luring yield-hunters by boosting their monthly dividends, even as they navigate the complexities of a high interest rate landscape. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot